Michael Salvatore

Michael Salvatore, PhD, is a Professor at the University of North Texas Health Science Center (UNTHSC), affiliated with the College of Biomedical and Translational Sciences, Institute for Healthy Aging, and Department of Pharmacology & Neuroscience. His research focuses on understanding the molecular basis of locomotor impairment in aging and Parkinson's disease, with a focus on dopamine regulation, neurotransmission, and growth factors. He holds a PhD in Neuroscience from Louisiana State University Health Sciences Center and a BA from Ohio Wesleyan University.

Dr. Salvatore's research includes projects funded by the Department of Defense, National Institute on Aging, and UNTHSC, focusing on interventions like exercise and calorie restriction to mitigate Parkinsonian symptoms. Key projects include investigating tyrosine hydroxylase expression, GDNF receptor roles, and dopamine signaling mechanisms in aging and Parkinson's models.

His publications (57 total) span 1992–2025, with recent work emphasizing exercise efficacy, PINK1 knockout effects, and dopamine regulation. Notable areas include the role of tyrosine hydroxylase phosphorylation in compensating for neuron loss and the impact of GFR-α1 receptors on neuroprotection. Collaborations involve multidisciplinary teams exploring animal models (rats/mice) and clinical correlations.

Dr. Salvatore's lab aims to translate findings into therapies targeting proteins involved in motor dysfunction. Current efforts include evaluating exercise-induced neuroplasticity and pharmacological interventions like ceftriaxone to delay disease progression.